자궁 매니퓰레이션 기기 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the uterine manipulation devices market size was valued at USD 351.80 million in 2025 and is estimated to grow from USD 370.51 million in 2026 to reach USD 479.92 million by 2031, at a CAGR of 5.32% during the forecast period (2026-2031).

This report is Segmented by Product Type (Disposable, Reusable, Hybrid), Tip Movement (Fixed/Static, Articulating Tiltable, Flexible), Procedure (Total Laparoscopic Hysterectomy, Robotic-Assisted Hysterectomy, and More), End User (Hospitals, Ambulatory Surgical Centers, Specialty Gynecology Clinics), and Geography (North America and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Uterine Manipulation Devices Market Trends and Insights

Rising adoption of minimally invasive hysterectomy procedures

Laparoscopic hysterectomy rates climbed from 11.3% in 2015 to 52.7% by 2020, and continued rising to approximately 58-62% by 2022-2023 as surgeon confidence and patient preference shifted toward shorter hospital stays and reduced pain. Enhanced visualization tools and wireless laparoscopy improve surgical ergonomics, prompting hospitals to invest in uterine manipulators with multi-plane articulation matched to robotic consoles. Medicare's site-neutral payments encourage outpatient hysterectomy, pushing ASCs to procure efficient devices that enable same-day discharge. Enhanced Recovery After Surgery protocols further prioritize instruments that minimize tissue trauma and bleeding, reinforcing demand for premium manipulators.

Shift toward single-use sterile devices to cut infection risk

Hospitals accelerate the move to disposable manipulators after CDC guidance warned that single-use items should not be reprocessed because of contamination risks. The Olympus MAJ-891 recall and FDA reprocessing warnings intensified scrutiny, prompting purchasing managers to favor sterile, ready-to-use instruments despite higher unit pricing. EU packaging-waste directives complicate adoption, requiring suppliers to demonstrate recycling pathways or sustainable materials for disposables. Low-volume centers still find disposables cost-effective because capital outlays for sterilizers outweigh per-case savings, while high-volume hospitals weigh hybrid options that balance infection control and expense.

Device-related perforation & litigation concerns

Uterine perforation occurs in 1% of hysteroscopic procedures and up to 4% in certain intrauterine interventions, stoking malpractice claims and insurance premiums. Lawsuits alleging thermal injury from robotic instrumentation have heightened scrutiny of all accessory devices, including manipulators, leading risk-averse surgeons to prefer established brands with long safety records. FDA warning letters demanding corrective actions on robotic systems add compliance pressures; hospitals now reinforce credentialing and simulation training, slowing adoption of unfamiliar manipulator designs. Legal precedent in the United States places manufacturer-equivalent liability on hospitals that reprocess single-use devices, discouraging reuse unless strict validation is documented.

Other drivers and restraints analyzed in the detailed report include:

1. Increasing prevalence of fibroids & gynecologic cancers
2. New reimbursement codes boosting laparoscopic surgery uptake
3. Inconsistent reprocessing rules for reusable devices

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Disposable designs accounted for 54.02% of uterine manipulation devices market share in 2025 thanks to heightened infection-control vigilance after well-publicized contamination events. Hospitals view single-use manipulators as an insurance policy against costly surgical site infections and complex sterility audits. Yet reusable instruments still appeal to high-volume centers that amortize sterilization equipment over thousands of cases. Manufacturers respond with hybrid, limited-use models that support 5-10 cycles, balancing waste reduction and cost; this niche is forecast for 6.05% CAGR, outpacing the overall uterine manipulation devices market.

Innovations in fluoro-elastomer materials allow reusable shafts to withstand more than 1,000 steam cycles without degradation, lowering life-cycle cost and boosting resilience against silicone shortages. RFID chips embedded in handles log sterilization counts and temperature exposure, feeding data into hospital asset-management platforms that trigger preventive maintenance alerts.

Articulating tiltable-tip devices dominated, representing 47.55% of uterine manipulation devices market size in 2025 as surgeons sought broader range of motion for complex robotic and laparoscopic cases. Fixed-tip models remain staples in straightforward procedures due to simplicity and lower price, but lack the angles needed for deep pelvic exposure. Flexible-tip manipulators-using polymer joints and cable drives-are forecast to post the fastest 6.44% CAGR because they pair with 3D imaging for real-time contouring of uterine position.

Robotic integration layers new expectations: automated "follow-me" algorithms match uterine displacement to camera movements, minimizing repositioning time and assistant fatigue. Academic prototypes cut operative time by 12% in early trials, pointing to future smart manipulators that learn surgeon preferences over repeated cases. The uterine manipulation devices market continues to reward suppliers that fuse mechanics, sensors and software into an intuitive ergonomic package preferred by high-volume gynecologic oncology teams.

Geography Analysis

North America preserved 41.90% uterine manipulation devices market share in 2025 on the back of early robotic adoption, robust reimbursement and a dense network of fellowship-trained minimally invasive gynecologic surgeons. U.S. hospitals routinely upgrade to articulating, sensor-enabled devices compatible with 4K visualization, while ASC chains drive volume for disposable kits that streamline turnover.

Europe follows with steady uptake as aging demographics push hysterectomy demand and sustainability legislation nudges hospitals toward reusable or hybrid manipulators meeting EU waste directives. Regional procurement consortia reward suppliers demonstrating carbon-neutral manufacturing processes, spurring R&D into biopolymer handles and recyclable packaging.

Asia-Pacific is the uterine manipulation devices market's growth engine, projected at 7.55% CAGR through 2031, propelled by rapid ASC construction, urban middle-class expansion and government funding for robotic platforms in China, India and South Korea. Surgeons in tier-2 Chinese cities increasingly perform laparoscopic hysterectomy using cost-effective disposables imported under local distribution partnerships, squeezing margins for premium brands but expanding unit volumes.

South America shows gradual adoption with Brazil and Mexico leading, constrained by currency volatility affecting import pricing. Middle East & Africa post incremental gains tied to private-sector hospital group investment in Gulf states and large-scale health-city initiatives, which include turnkey robotic suites requiring compatible manipulators. Donor-funded women's health programs in sub-Saharan Africa occasionally procure basic fixed-tip devices, but volumes remain modest.

1. The Cooper Companies
2. Karl Storz
3. Olympus
4. Richard Wolf
5. Cook Group
6. B. Braun
7. Laborie Medical Technologies
8. Applied Medical Resources
9. Conmed
10. Purple Surgical International
11. Utah Medical Products
12. ClearView Medical
13. Halder Medical
14. Mangeshkar Surgical
15. Aesculap

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising adoption of minimally invasive hysterectomy procedures
  • 4.2.2 Shift toward single-use sterile devices to cut infection risk
  • 4.2.3 Increasing prevalence of fibroids & gynecologic cancers
  • 4.2.4 New reimbursement codes boosting laparoscopic surgery uptake
  • 4.2.5 Proliferation of ambulatory surgery centers in Asia-Pacific
  • 4.2.6 Robotic-ready articulating manipulators enhance ergonomics
• 4.3 Market Restraints
  • 4.3.1 Device-related perforation & litigation concerns
  • 4.3.2 Inconsistent reprocessing rules for reusable devices
  • 4.3.3 Supply-chain tightness for medical-grade silicone & polymers
  • 4.3.4 EU plastics-waste rules curbing single-use adoption
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Intensity of Competitive Rivalry

5 Market Size & Growth Forecasts

• 5.1 By Product Type (Value)
  • 5.1.1 Disposable Uterine Manipulators
  • 5.1.2 Reusable Uterine Manipulators
  • 5.1.3 Hybrid Devices
• 5.2 By Tip Movement (Value)
  • 5.2.1 Fixed / Static Tip
  • 5.2.2 Articulating Tiltable Tip
  • 5.2.3 Flexible Tip
• 5.3 By Procedure (Value)
  • 5.3.1 Total Laparoscopic Hysterectomy
  • 5.3.2 Robotic-Assisted Hysterectomy
  • 5.3.3 Tubal Ligation & Fertility
  • 5.3.4 Endometrial Cancer Surgery
  • 5.3.5 Myomectomy & Fibroid Removal
  • 5.3.6 Other Gynecologic Surgeries
• 5.4 By End User (Value)
  • 5.4.1 Hospitals
  • 5.4.2 Ambulatory Surgical Centers
  • 5.4.3 Specialty Gynecology Clinics
• 5.5 By Geography (Value)
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 India
    • 5.5.3.3 Japan
    • 5.5.3.4 South Korea
    • 5.5.3.5 Australia
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 South America
    • 5.5.4.1 Brazil
    • 5.5.4.2 Argentina
    • 5.5.4.3 Rest of South America
  • 5.5.5 Middle East and Africa
    • 5.5.5.1 GCC
    • 5.5.5.2 South Africa
    • 5.5.5.3 Rest of Middle East and Africa

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 CooperSurgical Inc.
  • 6.3.2 KARL STORZ SE & Co. KG
  • 6.3.3 Olympus Corporation
  • 6.3.4 Richard Wolf GmbH
  • 6.3.5 Cook Medical LLC
  • 6.3.6 B. Braun Melsungen AG
  • 6.3.7 Laborie Medical Technologies
  • 6.3.8 Applied Medical Resources
  • 6.3.9 CONMED Corporation
  • 6.3.10 Purple Surgical International
  • 6.3.11 Utah Medical Products Inc.
  • 6.3.12 ClearView Medical
  • 6.3.13 Halder Medical
  • 6.3.14 Mangeshkar Surgical
  • 6.3.15 Aesculap AG

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-Need Assessment